Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bas P. H. Adriaansen"'
Autor:
Bas P. H. Adriaansen, Agustini Utari, Dineke Westra, Achmad Zulfa Juniarto, Mahayu Dewi Ariani, Annastasia Ediati, Mariska A. M. Schröder, Paul N. Span, Fred C. G. J. Sweep, Stenvert L. S. Drop, Sultana M. H. Faradz, Antonius E. van Herwaarden, Hedi L. Claahsen – van der Grinten
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionCongenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) or 11-hydroxylase deficiency (11OHD) is characterized by underproduction of cortisol and overproduction of adrenal androgens. These androgens lead to a variable
Externí odkaz:
https://doaj.org/article/48f6cb3fd87c455992e4f56a2d178f4c
Autor:
Edi A. Shafaay, Mohammed A. Aldriweesh, Ghadeer L. Aljahdali, Amir Babiker, Abdulrahman O. Alomar, Khulood M. Alharbi, Haneen Aldalaan, Ahmed Alenazi, Abdulaziz S. Alangari, Afaf Alsagheir, Bas P. H. Adriaansen, Hedi L. Claahsen – van der Grinten, Ibrahim Al Alwan
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundCongenital Adrenal Hyperplasia (CAH) is a chronic disease that requires lifelong treatment. Patients may face stigmatization, which may affect their quality of life (QoL). Therefore, we assessed the clinical characteristics and QoL of patie
Externí odkaz:
https://doaj.org/article/f68d8a30233d4103b98cc12588d0906c
Autor:
Bas P. H. Adriaansen, Mariska A. M. Schröder, Paul N. Span, Fred C. G. J. Sweep, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Congenital adrenal hyperplasia (CAH) due to 21α-hydroxylase deficiency (21OHD) or 11β-hydroxylase deficiency (11OHD) are congenital conditions with affected adrenal steroidogenesis. Patients with classic 21OHD and 11OHD have a (nearly) complete enz
Externí odkaz:
https://doaj.org/article/98e97c9d76e5434592ee3066ad8017d6
Autor:
Bas P. H. Adriaansen, Johannes S. Kamphuis, Mariska A. M. Schröder, André J. Olthaar, Carina Bock, André Brandt, Nike M. M. L. Stikkelbroeck, Eef G. W. M. Lentjes, Paul N. Span, Fred C. G. J. Sweep, Hedi L. Claahsen‐van der Grinten, Antonius E. van Herwaarden
Publikováno v:
Clinical Endocrinology, 97, 36-42
Clinical Endocrinology, 97, 1, pp. 36-42
Clinical Endocrinology, 97, 1, pp. 36-42
Contains fulltext : 251424.pdf (Publisher’s version ) (Open Access) OBJECTIVE: Treatment of congenital adrenal hyperplasia (CAH) patients with glucocorticoids is often challenging since there is a delicate balance between over- and undertreatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79934e0ceffa756f613fb8d8282b0e23
https://pubmed.ncbi.nlm.nih.gov/35150157
https://pubmed.ncbi.nlm.nih.gov/35150157